Navigation Links
Scientists Gain Insight Into Blood Cancer's Progression
Date:2/20/2009

Findings for chronic myeloid leukemia may have wider implications, researchers say

FRIDAY, Feb. 20 (HealthDay News) -- U.S. researchers say they've spotted a mechanism by which chronic myeloid leukemia (CML) progresses into a deadlier stage.

The finding may improve patient outcomes, they said.

The researchers found that when a molecular off-switch called glycogen synthase kinase (GSK) 3 beta becomes faulty in chronic stage CML cells, it fails to turn off another protein called beta-catenin. This enables pre-leukemia stem cells to develop into leukemia stem cells and increase their numbers, leading to the more dangerous "blast crisis" state of CML.

"If we can predict when a patient is moving from the chronic phase in CML to the blast crisis stage, then we can hopefully intervene before it's too late," study co-leader Dr. Catriona H.M. Jamieson, an assistant professor of medicine at the University of California, San Diego (UCSD) School of Medicine and director for Stem Cell Research at the Moores UCSD Cancer Center, said in a university news release.

Faulty GSK 3 beta also offers a potential treatment target, the researchers said. "This knowledge may enable us to design and develop more effective, personalized therapies for these patients," co-first author and staff research associate Annelie Abrahamsson said in the news release.

The study appears online in this week's issue of the Proceedings of the National Academy of Sciences.

The findings may not be limited to CML, the team noted.

"Downregulating beta-catenin and GSK deregulation may have other implications in many cancers," Jamieson said. "By studying CML, we can understand the molecular evolution of disease and the stepwise progression to cancer. It becomes a useful paradigm for understanding how cancers evolve and the pathways that are essential to escape the normal control mechanisms."

More information

The U.S. National Cancer Institute has more about chronic myeloid leukemia.



-- Robert Preidt



SOURCE: University of California, San Diego, news release, Feb. 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems
2. Two Scientists Honored with MetLife Foundation Awards for Medical Research in Alzheimers Disease
3. University of Ottawa Heart Institute Scientists Unlock Mechanism That Turns on Weight-Loss Gene
4. Scientists uncover secrets of potential bioterror virus
5. Scientists uncover indicator that warns leukemia is progressing to more dangerous form
6. In Month of the Heart, Scientists Identify Better Way to Predict Heart-Disease Risk
7. Scientists Heartened at Prospect of End to Stem Cell Ban
8. Scientists discover key factor in controlling the breakdown of bone
9. Team led by Scripps Scientists increases understanding of two types of blindness
10. CSHL scientists discover link between control of chromosome duplication and segregation
11. UCSB scientists make headway in understanding Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Gain Insight Into Blood Cancer's Progression
(Date:2/28/2017)... ... February 28, 2017 , ... Las Vegas Skin and Cancer Clinic (LVSCC) ... Friday, March 10, 2017, 4-7 pm PST. For more than six decades, LVSCC has ... the South Rancho neighborhood, has been renovated to provide medical and cosmetic dermatological products ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... healthcare automation intelligence company based in New York. , “Ensuring an intuitive, user-friendly ... workflow remains unaltered. Those two fundamental reasons are the reasons this acquisition is ...
(Date:2/28/2017)... ... 2017 , ... The role of females in the military, ... civilian life. Body image dissatisfaction is largely unexamined among female veterans, a rapidly ... of chronic mental health conditions than female civilians. Female veterans also are more ...
(Date:2/27/2017)... ... 27, 2017 , ... Bo Chen, PhD is the recipient of the 2017 ... during the Plenary Session at ASLMS 2017, the Annual Conference of the American Society ... April 5-9, 2017. , During the Plenary Session on April 7, Dr. Chen ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... the alternative health care industry, announces Chris Brandl as its New Guest Director. ... vision and purpose to corporations throughout his career. He began his professional career ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... 2017 Research and Markets has announced ... 2014-2025" report to their offering. ... The global digestive enzyme ... 2025. Growing consumer awareness regarding the severity of digestive disorders ... stimulate industry growth over the forecast period. The increasing incidence ...
(Date:2/28/2017)... , Feb 28, 2017 ... Research and Markets has ... report to their offering. The global orthobiologics ... The orthobiologics market is predominantly driven by the ... innovations in biomaterials, used in the production of orthobiologics are presumed ...
(Date:2/27/2017)... Health, Inc. (NYSE: HYH ) today reported fourth ... and related key planning assumptions. Executive Summary 2016 ... increase compared to the prior year. Net ... to net income of $15 million in the fourth quarter ... compared to adjusted net income of $27 million in the ...
Breaking Medicine Technology: